Table 2

Characteristics of melanomas diagnosed during the 2-year follow-up of the COPARIME cohort

	N°	Gender	Patient age at diagnosis	Healthcare pathway	Type	Localisation	Breslow index (mm)	Delay between GP consultation and excision (days)
1st year of COPARIME targeted screening	1	F	31	Compliant	SSM	Forearm	0.16	24
	2	F	73	Compliant	Dubreuilh	Face	0	49
	3	M	64	Compliant	SSM	Back	0.8	49
	4	M	40	Compliant	SSM	Forearm	0.49	54
	5	M	51	Compliant	SSM	Back	0.245	106
	6	M	75	Compliant	Dubreuilh	Forearm	0.18	108
	7	F	34	Compliant	SSM	Thigh	0.52	124
	8	F	34	Compliant	SSM	Thigh	0.15	124
	9	F	55	Patient's own initiative	SSM	Forearm	0	154
	10	M	56	Patient's own initiative	SSM	Back	0	286
2nd year of COPARIME targeted screening	11	F	71	Compliant	SSM	Thigh	0.45	33
	12	M	66	Compliant	Dubreuilh	Face	0	137
	13	M	59	Compliant	SSM	Bottom	0.38	191
	14	F	68	Referred in 2011, consulted after 2012 reminder	SSM	Calf	1.11	512
	15	M	42	Patient's own initiative	SSM	Back	0.43	513
	16	F	32	Referred in 2011, consulted after 2012 reminder	SSM	Back	0.242	709

	Breslow index (mm)			Delay between GP consultation and excision (days)
	1st year	2nd year	p Value	1st year	2nd year	p Value
Mean	0.25	0.43	0.33*	107.8	349	0.077*
Median	0.17	0.405	0.65†	107	351	0.15†

*Student's t test.
†Fisher test.
F, female; GP, general practitioner; M, Male; SSM, superficial spreading melanoma.